U.S. Stem Cell, Inc. (USRM)

U.S. Stem Cell Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Feb 6, 2026	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Market Capitalization	0	3	3	5	1	6
Market Cap Growth	-99.97%	0.79%	-43.15%	263.45%	-75.83%	-39.03%
Enterprise Value	-	13	12	12	8	10
Last Close Price	0.00	0.00	0.01	0.01	0.00	0.02
PS Ratio	0.01	37.11	15.05	19.18	0.48	0.90
PB Ratio	0.00	-0.21	-0.24	-0.46	-0.15	-0.88
P/FCF Ratio	-	-	-	-	-	10.04
P/OCF Ratio	-	-	-	-	-	10.04
EV/Sales Ratio	-	157.06	58.78	42.90	2.62	1.50
EV/FCF Ratio	-	-	-	-	-	16.65
Debt / Equity Ratio	-0.68	-0.68	-0.70	-0.72	-0.71	-0.77
Debt / FCF Ratio	-	-	-	-	-	8.77
Net Debt / Equity Ratio	-0.68	-0.68	-0.70	-0.72	-0.71	-0.57
Net Debt / EBITDA Ratio	-	-	-	-3.86	-2.70	-4.41
Net Debt / FCF Ratio	-33.06	-33.06	-8.44	-17.39	-5.53	6.52
Asset Turnover	1.38	1.38	2.89	3.11	3.22	3.92
Inventory Turnover	34.65	34.65	17.91	9.49	26.36	25.81
Quick Ratio	0.00	0.00	0.00	0.01	0.01	0.23
Current Ratio	0.01	0.01	0.00	0.01	0.01	0.26
Return on Assets (ROA)	-1806.65%	-1806.65%	-1918.66%	-1685.62%	-178.16%	-40.18%
Return on Capital Employed (ROCE)	12.30%	12.30%	17.80%	22.30%	31.40%	26.80%
Earnings Yield	-431713.44%	-93.85%	-108.81%	-54.40%	-262.33%	-35.71%
FCF Yield	-	-10.01%	-35.02%	-9.01%	-82.83%	9.96%
Buyback Yield / Dilution	-28.38%	-28.38%	-7.34%	-7.85%	-8.86%	-18.32%

Updated Apr 14, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.